These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2565378)

  • 1. Dual labelling of circulating CD8 cells in patients with multiple sclerosis.
    Hughes PJ; Kirk PF; Compston DA
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):118-21. PubMed ID: 2565378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.
    Kastrukoff LF; Paty DW
    Ann Neurol; 1984 Mar; 15(3):250-6. PubMed ID: 6232891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible in vivo modulation of Leu 2a expression on suppressor T cells in active multiple sclerosis.
    Thompson AJ; Brazil J; Whelan CA; Feighery C
    Immunol Lett; 1985; 10(3-4):189-91. PubMed ID: 2931357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis.
    Zaffaroni M; Rossini S; Ghezzi A; Parma R; Cazzullo CL
    J Neurol; 1990 Feb; 237(1):1-4. PubMed ID: 1969461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of circulating suppressor inducer T lymphocytes in the exacerbation phase of remitting-relapse multiple sclerosis.
    Cafaro A; Spadaro M; Pandolfi F; Tilia G; Scarselli E; Liberati F; Aiuti F
    Riv Neurol; 1987; 57(3):159-62. PubMed ID: 2960006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor T-lymphocytes in multiple sclerosis: analysis of patients with acute relapsing and chronic progressive disease.
    Paty DW; Kastrukoff L; Morgan N; Hiob L
    Ann Neurol; 1983 Oct; 14(4):445-9. PubMed ID: 6227277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing circulating OKT8 cell phenotypes in patients with multiple sclerosis.
    Hughes PJ; Kirk PF; Dyas J; Munro JA; Welsh KI; Compston DA
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1156-9. PubMed ID: 2959756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood lymphocyte phenotype and function in multiple sclerosis.
    Hughes PJ; Compston DA
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1187-92. PubMed ID: 2976082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surface phenotypes of peripheral blood mononuclear cells in multiple sclerosis].
    Wender M; Sniatała-Kamasa M
    Neurol Neurochir Pol; 1988; 22(3):177-83. PubMed ID: 2975766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methylprednisolone on lymphocyte phenotype and function in patients with multiple sclerosis.
    Kirk P; Compston A
    J Neuroimmunol; 1990 Jan; 26(1):1-8. PubMed ID: 1967180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of peripheral blood leukocytes in acute heatstroke.
    Bouchama A; al Hussein K; Adra C; Rezeig M; al Shail E; al Sedairy S
    J Appl Physiol (1985); 1992 Aug; 73(2):405-9. PubMed ID: 1399958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoimmunological dysregulation in multiple sclerosis.
    Foley FW; Miller AH; Traugott U; LaRocca NG; Scheinberg LC; Bedell JR; Lennox SS
    Psychosomatics; 1988; 29(4):398-403. PubMed ID: 2906448
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
    Morimoto C; Hafler DA; Weiner HL; Letvin NL; Hagan M; Daley J; Schlossman SF
    N Engl J Med; 1987 Jan; 316(2):67-72. PubMed ID: 2946956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subpopulations in patients with multiple sclerosis.
    Compston A
    J Neurol Neurosurg Psychiatry; 1983 Feb; 46(2):105-14. PubMed ID: 6221079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic immune response in multiple sclerosis: analysis of CSF inflammatory changes and peripheral blood T-cell subsets.
    Steck AJ; de Flaugergues JC
    J Neurol; 1984; 231(3):126-9. PubMed ID: 6332885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deficit of natural killer cells (NK cells) in the peripheral blood of patients with atopic dermatitis].
    Reinhold U; Wehrmann W; Bauer R; Kreysel HW
    Hautarzt; 1986 Aug; 37(8):438-43. PubMed ID: 2944856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1989 May; 25(5):494-9. PubMed ID: 2528316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.
    Thompson AJ; Brazil J; Martin EA; Hutchinson M; Whelan CA; Feighery C
    J Neurol Neurosurg Psychiatry; 1985 Oct; 48(10):1062-4. PubMed ID: 2932538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.